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Abstract
Background: Leishmania preferentially infects macrophages, which allow the parasite to multiply but can also kill
the parasite. Although the T cell response in human leishmaniasis is well-characterized, little is known about the
concomitant macrophage behavior. The aim of this study was to characterize the macrophage immune response
after Leishmania braziliensis infection in cells derived from cutaneous leishmaniasis (CL) or mucosal leishmaniasis
(ML) patients, subclinical individuals (SC) and healthy control subjects (HS).
Methods: Peripheral blood mononuclear cell-derived macrophages from the different groups were exposed to L.
braziliensis in vitro and were evaluated for susceptibility to Leishmania infection, ability to kill Leishmania and
chemokine/cytokine production. Nitric Oxide (NO) and superoxide (O2
-) levels in the supernatant of infected
macrophage cultures were monitored.
Results: After exposure to L. braziliensis, peripheral blood mononuclear cell-derived macrophages from SC
individuals showed a lower infection rate and a smaller number of intracellular amastigotes compared to cells from
CL and ML patients. Macrophages from CL and ML patients produced more chemokines and TNF-a than those
from the SC group. Production of NO and O2
- were detected but did not vary significantly among the different
groups.
Conclusions: Our data indicate that macrophages play a pivotal role in controlling L. braziliensis infection and in
leishmaniasis pathology by secreting pro-inflammatory chemokines/cytokines that activate and recruit T cells,
overwhelming the inflammatory response.
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Background
Leishmania Viannia braziliensis is the primary cause of
American Tegumentary Leishmaniasis (ATL) in Brazil.
Cutaneous leishmaniasis (CL), the most common form of
ATL, is characterized by the appearance of a single or a
few ulcerated skin lesions. A fraction (3%) of CL patients
develops mucosal disease, characterized by disfiguring
lesions that usually involve the nasal or oropharyngeal
mucosa [1,2]. CL and ML lesion biopsies show an intense
inflammatory reaction, characterized by a predominance
of lymphocytes and macrophages and few or no detect-
able parasites [1]. In areas of endemic Leishmania trans-
mission, approximately 10% of individuals have a positive
Montenegro skin test (MST) but lack disease pathology
[3-6]. These individuals are classified as subclinical (SC)
or asymptomatic infection cases. The immunological
response in CL and ML has been well-characterized. The
type-1 immune response predominates in CL and ML,
with an exaggerated production of IFN-g and TNF-a that
fails to be modulated either by IL-10 or TGF-b or by
neutralizing antibodies to IL-12 and IL-15 [7,8]. Lympho-
cytes from ML patients proliferate more than those from
CL patients when stimulated with parasite antigens and
produce higher levels of IFN-g and TNF-a [7,9]. This
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the disease and contributes to pathological tissue
damage. In contrast, SC patients produce only low levels
of IFN-g and TNF-a [10].
Macrophages, the host cells for the intracellular parasite
Leishmania, are crucial for the outcome of disease. How-
ever, very little is known about macrophage behavior in
human Leishmania infection. In addition to presenting
antigens to T cells, macrophages secret chemokines and
cytokines involved in the inflammatory response, such as
IL-1b and TNF-a in response to Leishmania infection.
Lesions from CL patients show increased expression of
CCL2, CXCL9 and CXCL10 [11]. CCL2 and CCL3 are
known to increase the leishmanicidal ability of human
macrophages to the same level induced by IFN-g [12].
However, molecules such CXCL9, CXCL10 and TNF-a,
which are highly expressed in the tissue from CL and ML
patients, participate in the inflammatory reaction that may
lead to the tissue damage observed in CL and ML [11,13].
When Leishmania parasites enter host macrophages, an
oxidative burst occurs that is characterized by an increase
in reactive oxygen species and reactive nitrogen intermedi-
ates, such as nitric oxide (NO). The mechanisms used by
human macrophages to kill Leishmania are not yet well
established. While NO production plays a role in killing
Leishmania in mice, its role in humans is still questionable
[14-16].
The aim of the present study was to characterize the
immune response of macrophages from CL, ML, and SC
patients and from healthy subjects (HS) after exposure to
Leishmania. We evaluated the susceptibility of macro-
phages to infection by L. braziliensis and the ability of
these cells to kill Leishmania. Additionally, we investigated
the role of NO and O2
- in killing the L. braziliensis para-
site. We also evaluated the production of chemokines
(CCL2, CCL3, CXCL8 and CXCL9) and TNF-a.
Methods
Subjects
This study included patients with CL (n = 22), ML (n =
11) or SC (n = 18) and HS controls (n = 14). All patients
were seen at Corte de Pedra Health Post, located in the
southeast region of the State of Bahia, Brazil, which is well
known for its high rate of L. braziliensis transmission.
Some experiments did not include samples from every
patient because some of the experiments in this study
required a larger number of cells than could be obtained
from the patients. The diagnostic criteria were a clinical
picture characteristic of CL or ML, parasite isolation or a
positive delayed-type hypersensitivity (DTH) response to
leishmania antigen, and histological features of CL or ML.
Household contacts of ATL patients without past or cur-
rent history of leishmaniasis with a positive DTH test and/
or IFN-g production in cultures stimulated with SLA were
considered as having subclinical infection. The physical
examination of these individuals did not show a typical
scar of CL. Immunological analyses were performed prior
to therapy for all patients. Healthy subjects were com-
posed of students at the Federal University of Bahia.
This study was approved by the Ethical Committee of
the Federal University of Bahia. Informed consent was
obtained from all enrolled subjects.
Parasites
A L. braziliensis (MHOM/BR/2003/LTCP15344) isolate
obtained from a skin lesion on a CL patient was initially
cultivated in biphasic medium (NNN). Following isolation,
the parasites were cryopreserved in frozen nitrogen. The
parasites selected for this study had not been previously
passaged in liquid culture medium. After selection, the
parasites were expanded in complete Schneider’s medium.
The isolate was identified as L. braziliensis by multilocus
enzyme electrophoresis [17].
Soluble leishmania antigen (SLA)
The leishmania lysate (crude antigen) was prepared
from a L. braziliensis strain (MHOM/BR/2001) as pre-
viously described [18].
Cell separation and macrophage culture
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from heparinized blood using Ficoll Hypaque (LSM;
Organon, Durham, NC). Monocytes were separated by
adherence. After 6 days of culture in complete RPMI
1640 (10% heat inactivated human AB serum, 100 U
penicillin/ml, 100 μg streptomycin/ml) (GIBCO BRL,
Grand Island, NY, USA), the adherent cells displayed
characteristics of monocytes-derived macrophages.
More than 99% of the cells in culture were identified as
macrophages by microscopic observation. To assess pur-
ity of macrophages, adherent cells were removed by har-
vesting and analyzed by flow cytometry. Macrophages
were gated according to their characteristic forward- and
side-scatter. Purity was assessed by analysis using the fol-
lowing conjugated mouse anti-human mabs: CD14-PE-
Cy5 (macrophages), CD3-PE (T cells), CD19- FITC (B
cells), and were confirmed to be CD14
+,C D 3
-,C D 1 9
-.
The T cell influence on the system was considered to be
absent because the adherent cell population consisted of
less than 1% CD3
+ T cells (data not shown). We also
evaluated the production of IFN-g in supernatants of
infected macrophages by ELISA and observed that the
IFN-g levels were very low or undetectable.
Macrophage infection by L. braziliensis and evaluation of
chemokines and TNF-a production
PBMC-derived macrophages from HS and from SC, CL
and ML patients were infected with L. braziliensis
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Page 2 of 9stationary phase promastigotes at a 2:1 ratio. Uninfected
macrophages and LPS-stimulated macrophages (100 ng/
ml) were used as controls. Infected macrophages were
i n c u b a t e da t3 7 ° Ci n5 %C O 2 for 2 h. After incubation,
the remaining extracellular parasites were removed by
gentle washing. Cells were stained with Giemsa stain
after 2, 48 and 96 h of infection, and the infection levels
were determined by counting the percentage of infected
cells and the number of amastigotes per 100 macro-
phages. This analysis was performed by two independent
observers who were blinded to the experimental condi-
tions. After each timepoint, supernatants were harvested
and stored at -70°C for analysis of chemokines, TNF-a
NO and O2
- production.
Determination of Nitric Oxide and superoxide production
Nitrite (NO2
-) accumulation in the cell culture superna-
tants was used as an indicator of NO production and was
determined by a standard Griess reaction [19]. Superoxide
production (O2
-) was determined by adding hydroxyla-
mine (0.5 mM) to cultures of infected macrophages
[20,21]. Hydroxylamine converts superoxide into nitrite,
which can be quantified by performing the Griess reaction,
as described above. Background levels of nitrite generated
by the release of NO were determined in parallel, without
the addition of hydroxylamine.
Determination of chemokines and TNF-a production
The cell culture supernatants from HS, SC, CL and ML
patients were assayed for CCL2, CCL3, CXCL8, CXCL9
and TNF-a after 2, 48 and 96 h of infection by ELISA (BD
Pharmingen and R&D Systems, Minneapolis, MN). Puri-
fied cytokines were used to derive a standard curve. The
sensitivity of the cytokine assays was 15.6 pg/ml (CXCL8),
15.6 pg/ml (CXCL9), 7.8 pg/ml (CCL2), 7.8 pg/ml (CCL3)
and 15.6 pg/ml (TNF-a).
Statistical analysis
Kruskal-Wallis with Dunn’s post-test was used to analyze
the results from the macrophage infection experiments
and to compare the levels of chemokines TNF-a,N Oa n d
O2
- produced by macrophages. The cut-off for statistical
significance was set at p < 0.05. Statistical analysis was per-
formed using Grand Prism 3.0 (GraphPad software, San
Diego, CA, USA)
Results
Susceptibility of human macrophages to L. braziliensis
infection
To determine the susceptibility of macrophages to L. bra-
ziliensis, as well as their ability to kill this parasite, adher-
ent cells from the 4 different groups of subjects (HS, SC,
CL and ML) were infected with L. braziliensis stationary
phase promastigotes. The percentage of infected cells and
the number of intracellular amastigotes/100 macrophages
were similar in the groups at 2 h after infection (Figures
1A and 1B). After 48 h, SC macrophages had a lower pro-
portion of infected cells and a lower number of amasti-
gotes per 100 cells compared to HS, CL and ML
macrophages (SC × HS, p < 0.001; SC × CL, p < 0.01; SC
×M L ,p < 0.001). After 96 h of infection, the percentage
of infected macrophages and number of amastigotes per
100 cells declined in all four groups. However, both values
were significantly lower in the SC patients compared to
HS and ML patients p <0.001 (Figures 1A and 1B).
L. braziliensis killing is not associated with NO and
superoxide production
L. braziliensis infection increased NO production and
the NO levels tended to be higher at 96 h of infection
(Figure 2A). This trend coincided with a significant
decrease in the intracellular parasite number in the SC
group. There was no statistical difference in NO pro-
duction among the groups (Figure 2A). Superoxide pro-
duction by human infected macrophages increased after
96 h of infection but there was no statistical difference
in superoxide production between the groups analyzed
after 48 and 96 h (Figure 2B).
Chemokines production by macrophages after infection
with L. braziliensis
Macrophages from all clinical forms produced low and
similar levels of chemokines at 2 h after infection (data
not shown). Figures 3 and 4 show the CCL2, CCL3,
CXCL8 and CXCL9 levels in the supernatants of L. brazi-
liensis-infected macrophages at 48 h of culture. CCL2
production was quite variable. CL macrophages (median
4660 pg/ml, range 0-31618 pg/ml) and ML macrophages
(6080 pg/ml, range 3600-25270) produced more CCL2
than SC cultures (median 447 range from 0 to 4700; p <
0.05) (Figure 3A). CXCL8 levels in CL (median 4790 pg/
ml, 960-16250 pg/ml) and ML (5360 pg/ml, 336-32100
pg/ml) cultures were also higher than in SC individuals
(570 pg/ml, 136-4980 pg/ml; p < 0.05) (Figure 3B). CCL3
was detected in all groups and did not show significant
differences among groups (data not shown). The levels of
CXCL9 were significantly higher in CL (1510 pg/ml, 0-
17205 pg/ml) and ML patients (16396 pg/ml, 4324-25080
pg/ml) compared with HS (66 pg/ml, 0-390 pg/ml; p <
0.001). SC patients produced less CXCL9 (265 pg/ml, 47-
2905) than either the ML and CL patients (p <0 . 0 0 1 ;p <
0.05) (Figure 4). At 96 h of culture the levels of chemo-
kines were still high (data not shown) and similar to the
levels at 48 h. No differences in LPS-induced CCL2,
CXL8 and CXCL9 production were observed between
groups (p > 0.05) (data not shown).
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L. braziliensis
Macrophages from CL, ML, SC and HS patients pro-
duced low and similar levels of TNF-a at 2 h after
infection (data not shown). At 48 h secreted TNF-a in
disease-specific patterns (Figure 5). Leishmania-infected
macrophages from ML and CL patients secreted more
TNF-a (64 pg/ml-ranging 1-341 pg/ml and 52 pg/ml,
ranging 0-170 pg/ml, respectively) than macrophages
from HS (0 pg/ml, ranging 0-74 pg/ml, p < 0.01 and p <
0.05). SC macrophages secreted less TNF-a (1.05pg/ml
and 0-6.2pg/ml respectively) than cells from ML and CL
patients p < 0.01 and p < 0.05 (Figure 5). At 96 h of cul-
ture the levels of TNF-a still were still high (data not
shown) and similar to levels at 48 h. No difference (p >
0.05) in LPS-induced TNF-a production was observed
between groups (data not shown).
Discussion
Macrophages are important for Leishmania infection
b e c a u s et h e yc a nh o s tt h ep a r a s i t ef o ral o n gp e r i o do f
time, act as antigen presenting cells and secrete molecules
that induce inflammatory response and may kill Leishma-
nia. In this study we compared the ability of L. braziliensis
to infect and survive in macrophages from individuals
with different clinical forms of L. braziliensis infection.
Furthermore, we measured molecules secreted by these
cells. Our data clearly show that individuals with SC
Figure 1 Phagocytosis and killing of L. braziliensis by macrophages from different forms of L. braziliensis infection. Human monocyte
derived-macrophages from HS (n = 12), SC (n = 12), CL (n = 10) and ML (n = 11) were infected with L. braziliensis in the stationary phase of
growth at a 2:1 ratio. The percentage of infected macrophages (A) and the parasite burden (B) were evaluated at 2, 48 and 96 h after infection.
Data represent the mean ± SD. Statistical analysis was performed using the Kruskal-Wallis test. (* p < 0.05, ** p < 0.01, *** p < 0.001).
Figure 2 Nitric Oxide (NO) and superoxide production by macrophages after infection with L. braziliensis. Six-day monocyte derived-
macrophages from HS (n = 6), SC (n = 6), CL (n = 6) and ML (n = 05) groups were infected or left uninfected with L. braziliensis at a 2:1 ratio.
After 48 and 96 h, the supernatants were collected for detection of NO (A) and superoxide (B) using the Griess reaction. The data are expressed
as the mean ± SD. Statistical analysis was performed using the Kruskal-Wallis test. (p > 0.05).
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absence of T cells or T cell products through the ability of
their macrophages to kill Leishmania.A l t e r n a t i v e l y ,
macrophages from CL and ML patients allow Leishmania
survival and produce high amounts of pro-inflammatory
chemokines that attract neutrophils, monocytes and
Figure 3 CCL2 and CXCL8 production by human macrophages infected in vitro with L. braziliensis. Six-day monocyte derived-macrophages
from HS (n = 14), SC (n = 12), CL (n = 16), and ML (n = 11) were infected with L. braziliensis at a 2:1 ratio. After 48 h, the supernatants were
harvested and the levels of CCL2 (A) and CXCL8 (B) were determined by ELISA. Each symbol represents a different patient, and each line represents
the median of a group. For statistical analysis, the Kruskal-Wallis nonparametric test was used. (*p < 0.05, **p < 0.01, *** p < 0.001).
Figure 4 CXCL9 production by infected human macrophages cultured in vitro in the presence of L. braziliensis.S i x - d a ym o n o c y t e
derived-macrophages from HS (n = 14), SC (n = 12), CL (n = 16), and ML (n = 11) were infected in vitro with L. braziliensis at a 2:1 ratio. After 48
h, the supernatants were harvested and the levels of CXCL9 were determined by ELISA. Each symbol represents a different patient, and each line
represents the median of a group. For statistical analysis, the Kruskal-Wallis test was used. (*p < 0.05; ***p < 0.001).
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contribute to the pathology associated with the L. brazi-
liensis infection.
Analyzing macrophage function in individuals with dif-
ferent clinical forms of L. braziliensis fills a gap in our
understanding of the pathogenesis of leishmaniasis. The
Th1-type immune response controls parasite multiplica-
t i o na n dd i s s e m i n a t i o ni nC La n dM L ,b u ti td o e sn o t
eradicate Leishmania infection [22]. Moreover, this exag-
gerated and non-modulated type-1 immune response
observed in CL and ML is associated with the production
of pro-inflammatory cytokines and tissue damage [7]. In
contrast, individuals with SC L. braziliensis infection con-
trol parasite growth and do not develop the disease,
despite producing only low levels of IFN-g,t h em a i n
cytokine that activates macrophages to kill Leishmania.
Therefore, it is likely that in SC individuals the innate
immune response plays an important role in the control
of parasite growth. Macrophages from sub-clinically
infected individuals have been shown to be susceptible to
infection by L. panamensis than macrophages from
patients with recurrent leishmaniasis [23]. In the present
study, all groups of macrophages infected with L. brazi-
liensis had equal numbers of amastigotes at two hours
after infection. We conclude that penetration of Leishma-
nia into macrophages is independent of the clinical
group from which the macrophage samples were
obtained. However, while the percentage of infected cells
and number of amastigotes decreased in macrophages
from individuals with SC infection, the parasite load in
CL and ML remained high, indicating that cells from SC
patients have a greater ability to kill parasites than cells
from CL and ML patients. The mechanisms used by
human macrophages to kill Leishmania are not yet well
established. NO plays an important role in controlling
established murine leishmaniasis infection [24]. A recent
study showed that NO production remained unchanged
in a co-culture of human neutrophils with macrophages
infected with L. braziliensis [25]. Our results show that
macrophages infected with L. braziliensis produced NO
and O2
-, although no differences were observed among
the different groups, suggesting that macrophage-derived
oxidants are not critical in controlling the macrophage
infection of Leishmaniasis patients by L. braziliensis.
Analyzing different isolates of Leishmania that originated
from patients with CL from an endemic area of L. brazi-
liensis transmission identified some isolates that were
resistant to death by NO, which positively correlated
with lesion size [26]. These data suggest that NO produc-
tion is not the main mechanism used by macrophages to
kill Leishmania. The interaction between NO and O2
-
leads to the formation of peroxynitrite (ONOO-ROS),
Figure 5 TNF-a production by human macrophages infected in vitro with L. braziliensis. Six-day monocyte derived-macrophages from HS
(n = 14), SC (n = 12), CL (n = 16), and ML (n = 11) were cultured in the presence of L. braziliensis at a 2:1 ratio. After 48 h, the supernatants
were harvested and the levels of TNF-a were determined by ELISA. Each symbol represents a different patient, and each line represents the
median of a group. For statistical analysis, the Kruskal-Wallis nonparametric test was used. (*p < 0.05; **p < 0.01).
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vitro in amastigotes when compared to NO [27,28].
Further studies are warranted to evaluate the role of per-
oxynitrite in the killing of L. braziliensis.
Chemokines participate in the inflammatory reaction
during Leishmania infection. While CCL3 was produced
in similar amounts by macrophages from all four
groups, the production of CCL2, CXCL8 and CXCL9
after L. braziliensis infection was significantly higher in
macrophages from CL and ML patients than in those
from SC patients. CXCL8 attracts neutrophils to the
inflammatory site where they are phagocytized by
macrophages. Depending on whether the neutrophils
are apoptotic or necrotic, macrophages can control or
allow parasite load growth [25,29]. Exogenous addition
of CCL2 is a highly specific chemotactic factor for
macrophages and T-lymphocytes that enhances L. infan-
tum killing by human macrophages [12]. This chemo-
kine showed increased expression in CL lesions
compared with control biopsy samples [30]. The expres-
sion of CCL2 and CXCL9 was higher in CL tissue cells
than in diffuse cutaneous leishmaniasis tissue [11].
CXCL9, previously called a monokine, is induced by
IFN-g (MIG) and has the ability to attract T cells to the
site of inflammation. These observations suggest that
different chemokines may influence the parasite multi-
plication, the inflammation and the clinical manifesta-
tions of leishmaniasis [12,30]. However, CL and ML
macrophages secreted higher levels of CCL2 and
CXCL9 but did not kill Leishmania,m a k i n gi tm o r e
likely that these chemokines are involved more in the
inflammatory reaction and tissue damage in CL and ML
patients than in protecting them against L. braziliensis
infection. CXCL9 is secreted in high levels in chronic
inflammatory and auto-immune diseases, such as
human T cell lymphotropic virus infection and multiple
sclerosis. In both cases, CXCL9 is associated with
inflammation and the disease pathology [31,32].
TNF-a plays an important role in protecting humans
and mice against leishmaniasis [33,34]. However, TNF-a
can also mediate the ATL pathology [35-39] Here, we
show that macrophages from CL and ML patients pro-
duce TNF-a after exposure to L. braziliensis infection.
Macrophages from CL and ML kill fewer parasites than
macrophages from SC, which implies that these cells
contribute to the pathology of CL and ML by producing
pro-inflammatory cytokines.
The explanation for why CL and ML groups produce
higher levels of chemokines and TNF-a is now under
evaluation. For instance genetic factors such as poly-
morphisms in TLR receptors may partly explain this dif-
ference. Alternatively, parasite factors may also stimulate
the production of chemokines and TNF-a. Recent stu-
dies have shown a RNA virus that actives TLR-3 in
some Leishmania species associated with mucosal dis-
ease [40]. This study builds on previous observations
that individuals with SC infection can control the L.
braziliensis parasite despite a poor type-1 immune
response [10], while the exaggerated inflammatory
response and T cell activation observed in CL and ML
contribute to the development of ulcers [35,41]. In this
research, we show that macrophages play a pivotal role
in the pathogenesis of tegumentary leishmaniasis by
decreasing the parasite load in subjects with subclinical
L. braziliensis infection, even in the absence of T cells
and inducing pathology in CL and ML patients, by
increasing pro-inflammatory chemokines and cytokines.
Conclusions
This study shows that macrophages may play a pivotal
role in the pathogenesis of human leishmaniasis and
that their function may determine the clinical outcome
of L. braziliensis infection. In SC disease, macrophages
efficiently kill parasites and control parasite growth
without tissue damage, while macrophages from CL and
ML patients allow parasite survival and secrete inflam-
matory molecules that activate and recruit other cells,
leading to pathology. The mechanisms for these findings
are not completely understood but provide a fascinating
subject for investigation.
Acknowledgements
We thank Elbe Silva, Maria Lúcia Reis and Cristiano S. Franco for secretarial
assistance. This study was supported by NIH grant AI088650, NIH grant
AI30639 and the Brazilian National Research Council (CNPq), Universal
472198/2009-2. EMC is a senior investigator of the CNPq and OB is an
investigator of the CNPq.
Author details
1Serviço de Imunologia, Complexo Hospitalar Universitário Professor Edgard
Santos, Universidade Federal da Bahia, Salvador, Bahia, Brazil.
2Instituto
Nacional de Ciência e Tecnologia de Doenças Tropicais- INCT-DT(CNPq/
MCT), Salvador, Bahia, Brazil.
3Complexo Hospitalar Universitário Prof. Edgard
Santos, Serviço de Imunologia, 5o andar, Rua João das Botas, s/n, Canela,
40110-160 Salvador, BA, Brazil.
Authors’ contributions
AG, CV, EMC and OB participated equally in the study design. AG, CV, LPC
and TL participated in the human macrophages infection and NO detection
experiments. AG, CV and CB participated in detecting the levels of
chemokines and TNF-α. EMC and OB are the principal investigators of this
work and followed the work from the beginning to the end and also
participated in the writing of the manuscript. All authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 14 October 2011 Accepted: 29 March 2012
Published: 29 March 2012
References
1. Bittencourt AL, Barral A: Evaluation of the histopathological classifications
of American cutaneous and mucocutaneous leishmaniasis. Mem Inst
Oswaldo Cruz 1991, 86(1):51-56.
Giudice et al. BMC Infectious Diseases 2012, 12:75
http://www.biomedcentral.com/1471-2334/12/75
Page 7 of 92. Marsden PD, Jones TC: Clinical manifestations, diagnosis and treatment of
leishmaniasis Amsterdam: Elsevier Science Publisher; 1985.
3. Ben Salah A, Louzir H, Chlif S, Mokni M, Zaatour A, Raouene M, Ismail RB,
Dellagi K: The predictive validity of naturally acquired delayed-type
hypersensitivity to leishmanin in resistance to Leishmania major-
associated cutaneous leishmaniasis. J Infect Dis 2005, 192(11):1981-1987.
4. Bittar RC, Nogueira RS, Vieira-Goncalves R, Pinho-Ribeiro V, Mattos MS,
Oliveira-Neto MP, Coutinho SG, Da-Cruz AM: T-cell responses associated
with resistance to Leishmania infection in individuals from endemic
areas for Leishmania (Viannia) braziliensis. Mem Inst Oswaldo Cruz 2007,
102(5):625-630.
5. Follador I, Araujo C, Orge G, Cheng LH, de Carvalho LP, Bacellar O,
Almeida RP, Carvalho EM: Immune responses to an inactive vaccine
against American cutaneous leishmaniasis together with granulocyte-
macrophage colony-stimulating factor. Vaccine 2002, 20(9-10):1365-1368.
6. Trujillo CM, Robledo SM, Franco JL, Velez ID, Erb KJ, Patino PJ: Endemically
exposed asymptomatic individuals show no increase in the specific
Leishmania (Viannia) panamensis-Th1 immune response in comparison
to patients with localized cutaneous leishmaniasis. Parasite Immunol
2002, 24(9-10):455-462.
7. Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro De Jesus A, Dutra WO,
Gollob KJ, Carvalho EM: Up-regulation of Th1-type responses in mucosal
leishmaniasis patients. Infect Immun 2002, 70(12):6734-6740.
8. Carvalho LP, Passos S, Bacellar O, Lessa M, Almeida RP, Magalhaes A,
Dutra WO, Gollob KJ, Machado P, de Jesus AR: Differential immune
regulation of activated T cells between cutaneous and mucosal
leishmaniasis as a model for pathogenesis. Parasite Immunol 2007,
29(5):251-258.
9. Carvalho EM, Johnson WD, Barreto E, Marsden PD, Costa JL, Reed S,
Rocha H: Cell mediated immunity in American cutaneous and mucosal
leishmaniasis. J Immunol 1985, 135(6):4144-4148.
10. Follador I, Araujo C, Bacellar O, Araujo CB, Carvalho LP, Almeida RP,
Carvalho EM: Epidemiologic and immunologic findings for the subclinical
form of Leishmania braziliensis infection. Clin Infect Dis 2002, 34(11):
E54-E58.
11. Ritter U, Korner H: Divergent expression of inflammatory dermal
chemokines in cutaneous leishmaniasis. Parasite Immunol 2002,
24(6):295-301.
12. Brandonisio O, Panaro MA, Fumarola I, Sisto M, Leogrande D,
Acquafredda A, Spinelli R, Mitolo V: Macrophage chemotactic protein-1
and macrophage inflammatory protein-1 alpha induce nitric oxide
release and enhance parasite killing in Leishmania infantum-infected
human macrophages. Clin Exp Med 2002, 2(3):125-129.
13. Faria DR, Gollob KJ, Barbosa J Jr, Schriefer A, Machado PR, Lessa H,
Carvalho LP, Romano-Silva MA, de Jesus AR, Carvalho EM, et al: Decreased
in situ expression of interleukin-10 receptor is correlated with the
exacerbated inflammatory and cytotoxic responses observed in mucosal
leishmaniasis. Infect Immun 2005, 73(12):7853-7859.
14. Assreuy J, Cunha FQ, Epperlein M, Noronha-Dutra A, O’Donnell CA, Liew FY,
Moncada S: Production of nitric oxide and superoxide by activated
macrophages and killing of Leishmania major. Eur J Immunol 1994,
24(3):672-676.
15. Evans TG, Thai L, Granger DL, Hibbs JB Jr: Effect of in vivo inhibition of
nitric oxide production in murine leishmaniasis. J Immunol 1993,
151(2):907-915.
16. Murray HW, Teitelbaum RF: L-arginine-dependent reactive nitrogen
intermediates and the antimicrobial effect of activated human
mononuclear phagocytes. J Infect Dis 1992, 165(3):513-517.
17. Cupolillo E, Grimaldi G Jr, Momen H: A general classification of New
World Leishmania using numerical zymotaxonomy. Am J Trop Med Hyg
1994, 50(3):296-311.
18. Reed SG, Badaro R, Masur H, Carvalho EM, Lorenco R, Lisboa A, Teixeira R,
Johnson WD Jr, Jones TC: Selection of a skin test antigen for American
visceral leishmaniasis. Am J Trop Med Hyg 1986, 35(1):79-85.
19. Ding AH, Nathan CF: The measurement of cytochrome b559 in
polymorphonuclear leukocytes and macrophages in the presence of
hemoglobin or mitochondrial cytochromes. Anal Biochem 1988,
175(1):22-29.
20. Elstner EF, Heupel A: Inhibition of nitrite formation from
hydroxylammoniumchloride: a simple assay for superoxide dismutase.
Anal Biochem 1976, 70(2):616-620.
21. Khouri R, Bafica A, Silva Mda P, Noronha A, Kolb JP, Wietzerbin J, Barral A,
Barral-Netto M, Van Weyenbergh J: IFN-beta impairs superoxide-
dependent parasite killing in human macrophages: evidence for a
deleterious role of SOD1 in cutaneous leishmaniasis. J Immunol 2009,
182(4):2525-2531.
22. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM: Cytokine
profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998,
31(1):143-148.
23. Bosque F, Saravia NG, Valderrama L, Milon G: Distinct innate and acquired
immune responses to Leishmania in putative susceptible and resistant
human populations endemically exposed to L. (Viannia) panamensis
infection. Scand J Immunol 2000, 51(5):533-541.
24. Liew FY, Cox FE: Nonspecific defence mechanism: the role of nitric oxide.
Immunol Today 1991, 12(3):A17-A21.
25. Novais FO, Santiago RC, Bafica A, Khouri R, Afonso L, Borges VM,
Brodskyn C, Barral-Netto M, Barral A, de Oliveira CI: Neutrophils and
macrophages cooperate in host resistance against Leishmania
braziliensis infection. J Immunol 2009, 183(12):8088-8098.
26. Giudice A, Camada I, Leopoldo PT, Pereira JM, Riley LW, Wilson ME, Ho JL,
de Jesus AR, Carvalho EM, Almeida RP: Resistance of Leishmania
(Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric
oxide correlates with disease severity in Tegumentary Leishmaniasis.
BMC Infect Dis 2007, 7:7.
27. Linares E, Augusto O, Barao SC, Giorgio S: Leishmania amazonensis
infection does not inhibit systemic nitric oxide levels elicited by
lipopolysaccharide in vivo. J Parasitol 2000, 86(1):78-82.
28. Van Assche T, Deschacht M, da Luz RA, Maes L, Cos P: Leishmania-
macrophage interactions: insights into the redox biology. Free Radic Biol
Med 2011, 51(2):337-351.
29. Afonso L, Borges VM, Cruz H, Ribeiro-Gomes FL, DosReis GA, Dutra AN,
Clarencio J, de Oliveira CI, Barral A, Barral-Netto M, et al: Interactions with
apoptotic but not with necrotic neutrophils increase parasite burden in
human macrophages infected with Leishmania amazonensis. J Leukoc
Biol 2008, 84(2):389-396.
30. Campanelli AP, Brodskyn CI, Boaventura V, Silva C, Roselino AM, Costa J,
Saldanha AC, de Freitas LA, de Oliveira CI, Barral-Netto M, et al:
Chemokines and chemokine receptors coordinate the inflammatory
immune response in human cutaneous leishmaniasis. Hum Immunol
2010, 71(12):1220-1227.
31. Guerreiro JB, Santos SB, Morgan DJ, Porto AF, Muniz AL, Ho JL, Teixeira AL
Jr, Teixeira MM, Carvalho EM: Levels of serum chemokines discriminate
clinical myelopathy associated with human T lymphotropic virus type 1
(HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1
carrier state. Clin Exp Immunol 2006, 145(2):296-301.
32. Trebst C, Ransohoff RM: Investigating chemokines and chemokine
receptors in patients with multiple sclerosis: opportunities and
challenges. Arch Neurol 2001, 58(12):1975-1980.
33. Kanaly ST, Nashleanas M, Hondowicz B, Scott P: TNF receptor p55 is
required for elimination of inflammatory cells following control of
intracellular pathogens. J Immunol 1999, 163(7):3883-3889.
34. Pizzorni C, Secchi ME, Cutolo M: Leishmaniasis in rheumatoid arthritis.
Reumatismo 2007, 59(3):235-239.
35. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Carvalho EM, Gollob KJ:
Activated inflammatory T cells correlate with lesion size in human
cutaneous leishmaniasis. Immunol Lett 2005, 101(2):226-230.
36. Da-Cruz AM, de Oliveira MP, De Luca PM, Mendonca SC, Coutinho SG:
Tumor necrosis factor-alpha in human american tegumentary
leishmaniasis. Mem Inst Oswaldo Cruz 1996, 91(2):225-229.
37. Bafica A, Oliveira F, Freitas LA, Nascimento EG, Barral A: American
cutaneous leishmaniasis unresponsive to antimonial drugs: successful
treatment using combination of N-methilglucamine antimoniate plus
pentoxifylline. Int J Dermatol 2003, 42(3):203-207.
38. Machado PR, Lessa H, Lessa M, Guimaraes LH, Bang H, Ho JL, Carvalho EM:
Oral pentoxifylline combined with pentavalent antimony: a randomized
trial for mucosal leishmaniasis. Clin Infect Dis 2007, 44(6):788-793.
39. Sadeghian G, Nilforoushzadeh MA: Effect of combination therapy with
systemic glucantime and pentoxifylline in the treatment of cutaneous
leishmaniasis. Int J Dermatol 2006, 45(7):819-821.
40. Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, Schutz F,
Zangger H, Revaz-Breton M, Lye LF, Hickerson SM, et al: Leishmania RNA
Giudice et al. BMC Infectious Diseases 2012, 12:75
http://www.biomedcentral.com/1471-2334/12/75
Page 8 of 9virus controls the severity of mucocutaneous leishmaniasis. Science 2011,
331(6018):775-778.
41. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicao-Silva F,
Modlin RL: Cytokine patterns in the pathogenesis of human
leishmaniasis. J Clin Invest 1993, 91(4):1390-1395.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/12/75/prepub
doi:10.1186/1471-2334-12-75
Cite this article as: Giudice et al.: Macrophages participate in host
protection and the disease pathology associated with Leishmania
braziliensis infection. BMC Infectious Diseases 2012 12:75.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Giudice et al. BMC Infectious Diseases 2012, 12:75
http://www.biomedcentral.com/1471-2334/12/75
Page 9 of 9